 NEWTON, Mass., Aug. 30, 2021 GLOBE NEWSWIRE -- Acer Therapeutics Inc. Nasdaq: ACER, a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acers management team will present and host one-on-one investor meetings at the upcoming H.C. Wainwright Global Investment Conference September 13-15, 2021. 